Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04205903Phase 1Completed
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
PrincipalinvestigatorStart date: 2020-12-11
NCT02831582Not ApplicableCompleted
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
ArthralgiaBreast Neoplasms
PrincipalinvestigatorStart date: 2016-10-12
NCT02125019Completed
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2013-12-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04205903Phase 1PrincipalInvestigator

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
Completed
NCT02831582Not ApplicablePrincipalInvestigator

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

ArthralgiaBreast Neoplasms
Completed
NCT02125019PrincipalInvestigator

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

Breast Cancer
Completed

All 3 trials loaded